These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 15158133)
21. Manipulating cardiac contractility in heart failure: data from mice and men. Dorn GW; Molkentin JD Circulation; 2004 Jan; 109(2):150-8. PubMed ID: 14734503 [No Abstract] [Full Text] [Related]
22. Role of phospholamban phosphorylation on Thr17 in cardiac physiological and pathological conditions. Mattiazzi A; Mundiña-Weilenmann C; Guoxiang C; Vittone L; Kranias E Cardiovasc Res; 2005 Dec; 68(3):366-75. PubMed ID: 16226237 [TBL] [Abstract][Full Text] [Related]
23. Two patterns of ion channelopathy in the myocardium: perspectives for development of anti-arrhythmic agents. Dai DZ Curr Opin Investig Drugs; 2005 Mar; 6(3):289-97. PubMed ID: 15816506 [TBL] [Abstract][Full Text] [Related]
24. [Safety evaluation of drugs on the cardiovascular system by the analysis of gene expression]. Sato Y Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2003; (121):112-4. PubMed ID: 14977013 [No Abstract] [Full Text] [Related]
25. Molecular properties of excitation-contraction coupling proteins in infant and adult human heart tissues. Jung DH; Lee CJ; Suh CK; You HJ; Kim DH Mol Cells; 2005 Aug; 20(1):51-6. PubMed ID: 16258241 [TBL] [Abstract][Full Text] [Related]
32. Diastolic dysfunction and the aging heart. Chiamvimonvat N J Mol Cell Cardiol; 2002 Jun; 34(6):607-10. PubMed ID: 12054847 [No Abstract] [Full Text] [Related]
33. [Calcium transporting system of the myocardial sarcoplasmic reticulum in experimental coronary circulatory disorders]. Frol'kis RA; Mkhitarian LS; Khil'ko OK Fiziol Zh (1978); 1981; 27(2):276-8. PubMed ID: 7238942 [No Abstract] [Full Text] [Related]
34. When the thyroid speaks, the heart listens. Sussman MA Circ Res; 2001 Sep; 89(7):557-9. PubMed ID: 11577018 [No Abstract] [Full Text] [Related]
35. Increased SR Ca2+ cycling contributes to improved contractile performance in SERCA2a-overexpressing transgenic rats. Maier LS; Wahl-Schott C; Horn W; Weichert S; Pagel C; Wagner S; Dybkova N; Müller OJ; Näbauer M; Franz WM; Pieske B Cardiovasc Res; 2005 Sep; 67(4):636-46. PubMed ID: 15932750 [TBL] [Abstract][Full Text] [Related]
36. The sarcoplasmic reticulum proteins are targets for calpain action in the ischemic-reperfused heart. Singh RB; Chohan PK; Dhalla NS; Netticadan T J Mol Cell Cardiol; 2004 Jul; 37(1):101-10. PubMed ID: 15242740 [TBL] [Abstract][Full Text] [Related]
37. Drug development based on functional genomics of overloaded cardiomyocytes: a novel approach for preventing progression of heart failure. Rupp H J Muscle Res Cell Motil; 2004; 25(8):608-9. PubMed ID: 16118846 [No Abstract] [Full Text] [Related]
38. Age-dependent suppression of SERCA2a mRNA in pediatric atrial myocardium. Pavlovic M; Schaller A; Pfammatter JP; Carrel T; Berdat P; Gallati S Biochem Biophys Res Commun; 2005 Jan; 326(2):344-8. PubMed ID: 15582584 [TBL] [Abstract][Full Text] [Related]